Characterization of Hyperprogression After Immunotherapy in a Lung Adenocarcinoma Patient With Strong Expression of Programmed Death Ligand 1
Overview
Overview
Journal
J Thorac Oncol
Publisher
Elsevier
Specialties
Oncology
Pulmonary Medicine
Pulmonary Medicine
Date
2019 Dec 23
PMID
31864557
Citations
3
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Li G, Choi J, Kryczek I, Sun Y, Liao P, Li S Cancer Cell. 2023; 41(2):304-322.e7.
PMID: 36638784 PMC: 10286807. DOI: 10.1016/j.ccell.2022.12.008.
Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer.
Ding P, Wen L, Tong F, Zhang R, Huang Y, Dong X Cancer Drug Resist. 2022; 5(1):147-164.
PMID: 35582541 PMC: 8992596. DOI: 10.20517/cdr.2021.104.
Wang J, Hong J, Yang F, Liu F, Wang X, Shen Z Cell Biol Toxicol. 2021; 39(3):1169-1180.
PMID: 34797429 DOI: 10.1007/s10565-021-09672-3.